Mattel’s stock rallies on news of acquisition offer as Hasbro may enter the fray

Date:

Share post:




Shares of Mattel Inc. jumped on Monday on a report saying that the private-equity firm L Catterton had come forward with an offer to acquire the toy maker — a move one analyst said wasn’t surprising given a long slump in the company’s stock price.



Source link

Alexandra Williams
Alexandra Williams
Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Recent posts

Related articles

RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.

President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human...

Here’s what bond and gold traders are signaling about Russia’s nuclear shift

Traditional flight-to-safety trades took off on Tuesday in response to a worsening conflict between Russia and Ukraine,...

Stock market ‘finally paying more attention to tariffs’ as a potential headwind

Tariffs have taken the spotlight as a policy issue as S&P 500 companies have discussed earnings with...

Investors are bracing for higher-for-even-longer interest rates

Friday’s stronger-than-expected economic data, combined with fresh remarks from Federal Reserve Chairman Jerome Powell on Thursday, were...

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs...

Manufacturing activity surges in New York region to highest level in nearly three years

The New York Federal Reserve’s Empire State business conditions index, a gauge of manufacturing activity in the...

RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Robert F. Kennedy Jr. would create “significantly more volatility” in health markets if he is confirmed as...

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Shares of vaccine makers lost ground Thursday, hit by news that President-elect Donald Trump was naming vaccine...